Phagocytosis

Phagocytosis
Name	Phagocytosis
Organism	Eukaryotes
Discovered	1882
Discoverer	Ilya Mechnikov

Phagocytosis

Phagocytosis is a cellular process central to innate immunity, development, and tissue homeostasis. First described by Ilya Mechnikov in the late 19th century, it has been studied across models from Homo sapiens to Dictyostelium discoideum and linked to findings by laboratories at institutions such as the Pasteur Institute, Rockefeller University, and Max Planck Society. Seminal experiments by researchers affiliated with University of Oxford, Harvard University, University of Cambridge, and Stanford University helped integrate observations with concepts from investigators associated with Royal Society, Nobel Prize, and historical figures like Louis Pasteur and Robert Koch.

Overview

Phagocytosis is performed by specialized cells including professional phagocytes like macrophages, neutrophils, and dendritic cells discovered in studies involving John Hunter-era anatomists and later characterized at Johns Hopkins University, University College London, and University of Pennsylvania. It involves engulfment of particles such as bacteria observed by researchers at Wellcome Trust-funded labs, and apoptotic corpses noted during investigations by groups at Cold Spring Harbor Laboratory and Salk Institute. Work conducted in contexts like World War I and institutions like Red Cross influenced clinical appreciation, while cellular models from University of Tokyo and University of California, Berkeley expanded mechanistic understanding.

Mechanism

The mechanism begins with recognition and binding, a step clarified by studies at Massachusetts Institute of Technology and California Institute of Technology, followed by actin-driven membrane remodeling characterized in research linked to Francis Crick-adjacent groups and laboratories at MRC Laboratory of Molecular Biology. Particle internalization proceeds via membrane cup formation and phagosome sealing, processes examined by investigators at National Institutes of Health, European Molecular Biology Laboratory, and Karolinska Institutet. Subsequent phagosome maturation, acidification, and fusion with lysosomes were described in work from Yale University, University of Chicago, and ETH Zurich, paralleling studies on endosomal trafficking from teams at Princeton University and University of California, San Diego.

Cellular and Molecular Components

Professional phagocytes were defined using methods developed at Imperial College London and University of Toronto; relevant surface receptors include Fc receptors identified in clinical research at Mayo Clinic and complement receptors characterized by investigators associated with NIH Clinical Center. Scavenger receptors and pattern recognition receptors emerged from studies at University of Washington and Uppsala University, while opsonins such as antibodies and complement components were traced to immunology groups at The Rockefeller University and Institut Pasteur. Intracellularly, actin cytoskeleton remodeling involves proteins studied at EMBL, University of Geneva, and John Innes Centre, with small GTPases (e.g., Rac, Cdc42) elucidated by labs at Cold Spring Harbor Laboratory and The Scripps Research Institute. Lysosomal hydrolases and NADPH oxidase complexes were characterized by contributors from St. Jude Children’s Research Hospital, Baylor College of Medicine, and Karolinska Institutet.

Physiological Roles and Examples

In host defense, phagocytic clearance of pathogens was documented in clinical series at Mayo Clinic and outbreak investigations by Centers for Disease Control and Prevention, with examples including responses to bacteria studied during the Spanish flu era and more recent analyses at World Health Organization collaborations. During development, phagocytosis-mediated remodeling was reported in developmental biology programs at Stanford University and Princeton University, paralleling findings in model organisms maintained at European Molecular Biology Laboratory and Model Organism Databases. Tissue-specific clearance by Kupffer cells, microglia, and alveolar macrophages has been described in research from Mount Sinai Hospital, Cleveland Clinic, and Beth Israel Deaconess Medical Center. Phagocytosis contributes to outcomes in transplantation studied at Massachusetts General Hospital and to tumor-associated macrophage behavior investigated by teams at Dana-Farber Cancer Institute and Memorial Sloan Kettering Cancer Center.

Regulation and Signaling Pathways

Regulatory networks involve cytokines and chemokines characterized in clinical immunology at National Institutes of Health and European Centre for Disease Prevention and Control, with growth factors studied at Howard Hughes Medical Institute-funded labs. Signaling pathways including Src-family kinases, Syk, PI3K, and downstream MAPK cascades were dissected in molecular biology centers at Max Planck Institute for Biochemistry, MRC Laboratory of Molecular Biology, and Institute of Cancer Research. Cross-talk with adaptive immunity through antigen presentation was elaborated by investigators at University of Oxford and Beth Israel Deaconess Medical Center, while metabolic regulation of phagocytes and links to autophagy were explored at Broad Institute and Johns Hopkins University.

Clinical Significance and Dysregulation

Defects in phagocytosis underlie diseases characterized by impaired clearance, such as chronic granulomatous disease studied at National Institutes of Health clinics and hereditary immunodeficiencies characterized at Great Ormond Street Hospital. Excessive or misdirected phagocytosis contributes to autoimmunity reviewed in symposia at American Medical Association-associated meetings and to atherosclerotic plaque formation investigated by researchers at Cleveland Clinic and Mount Sinai Hospital. Therapeutic manipulation of phagocytosis is an active area pursued by pharmaceutical companies in collaboration with institutions like Novartis, Pfizer, Roche, AstraZeneca, and translational centers at University of Pennsylvania and MD Anderson Cancer Center; approaches include opsonizing antibodies, blockade of inhibitory receptors described in oncology trials at Memorial Sloan Kettering Cancer Center, and gene therapies developed with input from Bill & Melinda Gates Foundation-funded programs.

Category:Cell biology